Carmine Liberatore: Limited Accuracy of VTE Risk Scores in Multiple Myeloma
Carmine Liberatore, Researcher at the University of “Gabriele d’Annunzio,” shared a post on LinkedIn about a recent article he and his colleagues co-authored, published in Therapeutic Advances in Hematology, adding:
”Finally, finally, finally out!
Currently available VTE risk scores demonstrated moderate to poor prognostic accuracy in predicting VTE events in multiple myeloma patients treated with Dara-Rd and concomitant LMWH-ASA thromboprophylaxis.
A long trip and successful collaboration with colleagues and friends at Università degli Studi G.d’Annunzio Chieti-Pescara․”
Title: Real-life venous thromboembolism risk scores in multiple myeloma receiving daratumumab, lenalidomide, and dexamethasone
Authors: Carmine Liberatore, Matteo Candeloro, Francesca Fioritoni, Nicola Potere, Simone Ciavarella, Desiree Tuosto, Stefano Pulini, Ettore Porreca, Marcello Di Nisio, Mauro Di Ianni
Stay updated on all scientific advances with Hemostasis Today.
-
Oct 16, 2026, 16:01Obi Light Ogbonnia: The Greatest Reward Is Changing Lives, Not Winning Awards
-
Oct 16, 2026, 14:55Alex Borstein and the Bleeding Phenotype of Hemophilia A Carriers
-
Oct 16, 2026, 13:59Aya Akmal Amin: Antiphospholipid Syndrome Management and Risk Stratification
-
Oct 16, 2026, 13:10Emanuel Sueldo: CAHT 2026 Celebrates Scientific Progress and Team Achievements
-
Oct 16, 2026, 13:05Maha Othman: Queen’s Health Sciences Advances CAT Risk Models and Pediatric ISTH-BAT Cut-Offs
-
Oct 16, 2026, 13:03Thrombosis Awareness Must Lead to Timely Action – Roche
-
Oct 16, 2026, 12:49Wolfgang Miesbach: 5-Year CBDR Data Confirms Emicizumab Safety and Efficacy in Hemophilia A
-
Oct 16, 2026, 12:40Edward Lee Carter: How Factor XI Inhibition Could Transform Anticoagulation Therapy
-
Oct 16, 2026, 12:40Marc Carrier: Looking Ahead to ISTH 2027 in Vancouver